Challenges in Assessing the Process–Outcome Link in Practice

Journal of General Internal Medicine

Volumn 30, Issue 3, 2015, Pages 359-364

  Parast, Layla ^a   Doyle, Brian ^b   Damberg, Cheryl L ^a   Shetty, Kanaka ^a   Ganz, David A ^a,b,c   Wenger, Neil S ^a,b   Shekelle, Paul G ^a,b,c  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

medicare; preventive care; program evaluation; quality improvement; randomized trials

Indexed keywords

HEALTH CARE QUALITY; HUMAN; OBSERVATIONAL STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; STANDARDS;

HUMANS; OBSERVATIONAL STUDIES AS TOPIC; PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REIMBURSEMENT, INCENTIVE;

EID: 84939970863     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-014-3150-0     Document Type: Article

References (31)

1. Centers for Medicare and Medicaid Services. Hospital Quality Initiative. Available at: http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/index.html. Accessed October 16, 2014.
2. Centers for Medicare and Medicaid Services. CMA Quality Initiatives. Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityInitiativesGenInfo/index.html?redirect=/QualityInitiativesGenInfo/01_overview.asp. Accessed October 16, 2014.
3. Beta-Blocker Heart Attack Study Group. The beta-blocker heart attack trial. JAMA. 1981;246(18):2073–2074.
4. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304(14):801–807.
5. Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet. 1981;2(8251):823–827.
6. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27(5):335–371.
7. Gunnar RM, Bourdillon PD, Dixon DW, et al. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early management of patients with acute myocardial infarction). Circulation. 1990;82(2):664–707.
8. National Committee for Quality Assurance (NCQA). HEDIS and Performance Measurement.; Available at: http://www.ncqa.org/HEDISQualityMeasurement.aspx, Accessed on October 16, 2014.
9. Kramer JM, Hammill B, Anstrom KJ, et al. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J. 2006;152(3):454 e451–458.
10. Mencke NM, Alley LG, Etchason J. Application of HEDIS measures within a Veterans Affairs medical center. Am J Manag Care. 2000;6(6):661–668.
11. Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA. 2010;303(24):2479–2485.
12. Werner RM, Bradlow ET. Relationship between Medicare’s hospital compare performance measures and mortality rates. JAMA. 2006;296(22):2694–2702.
13. Jha AK, Joynt KE, Orav EJ, Epstein AM. The long-term effect of premier pay for performance on patient outcomes. N Engl J Med. 2012;366(17):1606–1615.
14. Ingraham AM, Cohen ME, Bilimoria KY, et al. Association of surgical care improvement project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg. 2010;211(6):705–714.
15. Werner RM, Konetzka RT, Stuart EA, Norton EC, Polsky D, Park J. Impact of public reporting on quality of postacute care. Health Ser Res. 2009;44(4):1169–1187.
16. Lilford RJ, Chilton PJ, Hemming K, Girling AJ, Taylor CA, Barach P. Evaluating policy and service interventions: framework to guide selection and interpretation of study end points. BMJ. 2010;341:c4413.
17. Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86.
18. Werner RM, Bradlow ET. Public reporting on hospital process improvements is linked to better patient outcomes. Health Aff. 2010;29(7):1319–1324.
19. Ryan AM, Nallamothu BK, Dimick JB. Medicare’s public reporting initiative on hospital quality had modest or no impact on mortality from three key conditions. Health Aff. 2012;31(3):585–592.
20. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994;272(2):122–124.
21. Isis I, Collaborative Group. Randomized trial of intravenous atenolol among 16027 cases of suspect acute myocardial infarction. Lancet. 1986;2:57–66.
22. Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422.
23. Doran T, Fullwood C, Reeves D, Gravelle H, Roland M. Exclusion of patients from pay-for-performance targets by English physicians. N Engl J Med. 2008;359(3):274–284.
24. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ. 1995;311(7008):793–796.
25. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730–1737.
26. Official Hospital Compare Data. Centers for Medicare & Medicaid Services. Available at: https://data.medicare.gov/data/hospital-compare. Accessed on October 16, 2014.
27. Sin DD, McAlister FA. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med. 2002;113(8):650–656.
28. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol. 1996;25(6):1107–1116.
29. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics. 1998;54(3):948–963.
30. Vanderweele TJ, Arah OA. Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders. Epidemiology. 2011;22(1):42–52.
31. Centers for Medicare and Medicaid Services. Hospital Inpatient Quality Reporting Program: Process of Care Measures. Available at: https://www.cms.gov/Medicare/ Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/ HospitalProcessOfCareMeasures.html. Accessed October 16, 2014.